Shree Shailya Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 157.99%
- Profit Growth 710.43%
- Ebitda 268.99%
- Net Worth 1600.99%
- Total Assets 63.40%
About Shree Shailya Biotech
Shree Shailya Biotech Private Limited (SSBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 2011 and has a history of 14 years. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdish Rajegaikwad, Anita Rajegaikwad, and Prerana Pawar serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100PN2011PTC138285
- Company No.
138285
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Shree Shailya Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Rajegaikwad  | Director | 10-Jan-2022 | Current |
| Anita Rajegaikwad | Director | 17-Jan-2011 | Current |
| Prerana Pawar | Director | 08-Feb-2018 | Current |
Financial Performance of Shree Shailya Biotech.
Shree Shailya Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 157.99% increase. The company also saw a substantial improvement in profitability, with a 710.43% increase in profit. The company's net worth Soared by an impressive increase of 1600.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Shailya Biotech?
In 2019, Shree Shailya Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Shailya Mining Private LimitedJagdish Rajegaikwad, Anita Rajegaikwad and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shree Shailya Biotech?
Unlock and access historical data on people associated with Shree Shailya Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Shailya Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Shailya Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
